%0 Journal Article
%A Ruiz-Villaverde, Ricardo
%A Rivera-Izquierdo, Mario
%A Gil-Villalba, Ana
%A Pegalajar-Garcia, Maria D
%A Perez-Rojas, Javier
%A Soler-Iborte, Eva
%A Valero-Ubierna, M Carmen
%T Dermatological adverse reactions after vaccination with BNT162b2 in a cohort of healthcare workers.
%D 2022
%U http://hdl.handle.net/10668/19967
%X The description of the skin reactions produced by the different vaccines against SARS-CoV-2 has focused on the symptoms reported by the general population. There are few studies with very different measurement methods focused on healthcare workers. A longitudinal observational study was conducted on all the healthcare workers from the Hospital Universitario San Cecilio that received vaccination against COVID-19 with BNT162b2. The recruitment period was from December 2020 to September 2021. The recommended regimen was double, with a minimum interval of 21 days between doses. All dermatological reactions reported as adverse effects of the vaccine were evaluated by the Staff of the Dermatology Unit of our center. A total of 3969 healthcare workers of our center were followed. Only 0.7% of them reported dermatological adverse reactions. The most frequently reported reactions were morbilliform rash and COVID arm. In the multivariate analysis, the vaccination regimen (one dose) and the history of COVID-19 infection remained the main factors associated with the report of dermatological adverse reactions. The rate of dermatological adverse reactions after vaccination with BNT162b2 (Pfizer-BioNTech) is extraordinarily low. No patient required hospitalization, which supports the safety of this vaccination in a population of healthcare workers.
%K Análisis multivariante
%K Dermatología
%K Exantema
%K Infecciones
%~